#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Imagine if you could turn the characteristics of a cell on and
off… or up and down like a volume trigger… constantly tuning
things until everything is working just right. It might sound
impossible, but that’s exactly what Obsidian therapeutics is
working on.

I’ll admit, it was tough for me to wrap my mind around this one
at first, but my guest today did a fantastic job of explaining
things. So without further ado, chief development officer of
Obsidian therapeutics, Catherine Stehman-Breen.

Podcast notes and transcript available here:
https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics


-James Ruhle, SimpleBioTechPodcast.com

Stay up to date with the latest episodes and BioTech updates by
following me on instagram @SimpleBioTech

If you want to know which BioTech companies I'm currently excited
about, connect with me on Angel List at Angel.co/jamesruhle